In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal endothelial disease.

Please provide your email address to receive an email when new articles are posted on . James Funderburgh, PhD, at the University of Pittsburgh discovered stem cells in the corneal stroma in an ...

AURN001 is a combination cell therapy product candidate comprised of allogeneic human corneal endothelial cells ... assessed using the Visual Function Questionnaire (VFQ-25), was noted with ...

This structural knowledge can inform the development of targeted therapies aimed at restoring the function of the mutated protein. Corneal Endothelium: A layer of cells on the inner surface of the ...

In 2022, doctors in Japan performed a transplant of iPS cell-derived corneal endothelial cells iPS cell derived-corneal endothelial cell transplants are injected and take about 20 minutes In Japan ...

The cornea serves several functions, including refraction ... and the innermost endothelium, a single-cell-thick layer that pumps fluid from the collagenous stroma to maintain proper corneal ...

According to the company, the implantation demonstrated significant improvements in both distance and near vision, with manageable safety outcomes and minimal impact on corneal endothelium cell ...